D-192-2013 Class II Terminated

Recalled by K C Pharmaceuticals Inc — Pomona, CA

FDA drug recall D-192-2013 was initiated by K C Pharmaceuticals Inc on Mar 1, 2010 and is designated Class II. Reason for recall: Labeling: Label Mix-Up: Incorrect back labeling of the immediate container of eye drops (unit carton and front label are correct) which do not list three active ingredients: Dextran 70, PEG 400, and… The recall status is terminated (terminated Apr 2, 2013). Affected quantity: 31,704 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 20, 2013
Initiation Date
Mar 1, 2010
Termination Date
Apr 2, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
31,704 bottles

Product description

Eye Drops advanced relief (Dextran 70 0.1%, Polyethylene glycol 400 1%, Povidone 1%, Tetrahydrozoline HCl 0.05%) ophthalmic solution, 1/2 fl oz (15 mL) bottle, Distributed By Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37072.

Reason for recall

Labeling: Label Mix-Up: Incorrect back labeling of the immediate container of eye drops (unit carton and front label are correct) which do not list three active ingredients: Dextran 70, PEG 400, and povidone.

Distribution pattern

Nationwide

Code information

Lot #: 9P367, Exp 12/12

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-192-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-192-2013. Report a data issue: hello@regdatalab.com.